Stereoselective Cytotoxicity of Enantiopure 3,3-Dichloro-γ-lactams: Correlating In Vitro Activity with In Vivo Tolerability
Molecules · 2025
DOI: 10.3390/molecules30244778 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Faïza Diaba und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratori de Química Orgánica, Facultat de Farmàcia i Ciències de l'Alimentació, Institut de Biomedicina de la Universitat de Barcelona (IBUB), Univ…. Hauptthemen laut MEDLINE: Lactams, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundació Bosch i Gimpera.
Abstract (Originalsprache)
Enantiopure γ-lactams have emerged as promising scaffolds for anticancer drug development, yet the influence of stereochemistry on their biological activity remains insufficiently explored. In this study, we evaluated the in vitro cytotoxicity and in vivo toxicity of selected enantiopure 3,3-dichloro-γ-lactams and their corresponding epimers, with particular focus on their selectivity toward tumor versus non-tumor cells. The compounds were synthesized through green photoredox processes and tested for cytotoxicity using MTT and NRU assays in human cancer cell lines (A431, HeLa, MCF-7) and non-tumor controls (3T3, HaCaT). Toxicity and tolerability were further assessed in vivo using zebrafish (Danio rerio) embryos. Among the series, compound 3 displayed the most favorable selectivity index, combining potent anticancer effects with reduced activity toward non-tumor cells (HaCaT). Consistent with the in vitro results, compound 3 also demonstrated superior tolerability in zebrafish embryos compared with compound 4. These findings highlight the critical role of stereochemistry in modulating the cytotoxic and safety profiles of γ-lactams. Overall, compound 3 ((R)-3,3-dichloro-4-methyl-1-((S)-1-phenylethyl)pyrrolidin-2-one) emerges as a promising candidate for further preclinical development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratori de Química Orgánica, Facultat de Farmàcia i Ciències de l'Alimentació, Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Av. Joan XXIII 27-31, 08028 Barcelona, Spain.
- GRET-Unitat de Toxicologia, Departamento de Farmacología, Toxicología y Química Terapéutica, Facultat de Farmàcia i Ciències de l'Alimentació, Institut de Recerca en Nutrició i Seguretat Alimentària (INSA), Universitat…
- Departament de Bioquímica i Fisiologia-Secció de Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentaciò, Universitat de Barcelona, Av. Joan XXIII 27-31, 08028 Barcelona, Spain.
- Institut de Nanociència i Nanotecnologia-IN2UB, Universitat de Barcelona, Av. Diagonal, 645, 08028 Barcelona, Spain.
ORCID-Profile: Faïza Diaba, Elisabet Teixidó, María Del Carmen Morán
Förderung
- Fundació Bosch i Gimpera
Zitieren
APA
Diaba, F., Teixidó, E., & Morán, M. D. C. (2025). Stereoselective Cytotoxicity of Enantiopure 3,3-Dichloro-γ-lactams: Correlating In Vitro Activity with In Vivo Tolerability. Molecules. https://doi.org/10.3390/molecules30244778
Vancouver
Diaba F, Teixidó E, Morán MDC. Stereoselective Cytotoxicity of Enantiopure 3,3-Dichloro-γ-lactams: Correlating In Vitro Activity with In Vivo Tolerability. Molecules. 2025. doi:10.3390/molecules30244778
BibTeX
@article{Diaba2025,
author = {Diaba, Faïza and Teixidó, Elisabet and Morán, María Del Carmen},
title = {Stereoselective Cytotoxicity of Enantiopure 3,3-Dichloro-γ-lactams: Correlating In Vitro Activity with In Vivo Tolerability},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30244778}
}
EUVIMED